Becker's ASC Review

January/February 2021 Issue of Becker's ASC Review

Issue link: https://beckershealthcare.uberflip.com/i/1334878

Contents of this Issue

Navigation

Page 53 of 55

54 HEALTHCARE NEWS ADVERTISINGINDEX Note: Ad page number(s) given in parentheses ADVERTISER BD. bd.com/sterilesolution (pg. 15) Compulink Healthcare Solutions. compulinkadvantage.com/ascehr / (805) 716-8688 (pg. 13) DJO. djoglobal.com/motionmd / djoglobal.com/veripro (pgs. 40-43) Innomed. info@innomed.net / innomed.net / (800) 548-2362 (pg. 45) Innovative Medical Products. impmedical.com / (860) 560-1331 (pg. 27) Innovative Sterilization Technology. onetray.com/ce / (937) 619-0138 (pg. 2) National Medical Billing Services. nationalascbilling.com / (866) 948-8001 (pg. 56) OutcomeMD. rsaliman@outcomemd.com / calendly.com/rsaliman (pg. 25) Pacira BioSciences. exparel.com/reimbursement (pgs. 9-10) ServiceMaster Clean. servicemasterclean.com / (844) 325-0707 (pg. 35) Stryker. stryker.com/asc (pg. 3) Surgery Partners. surgerypartners.com (pg. 7) Surgical Notes. sales@surgicalnotes.com / surgicalnotes.com / (800) 459-5616 (pg. 55) How Providence vaccinated more than half of its 120,000 employees across 7 states By Kelly Gooch A my Compton-Phillips, MD, execu- tive vice president and chief clinical officer of Providence, told CNBC the Renton, Wash.-based health system has had a timely rollout of the COVID-19 vaccine to employees thanks to artificial intelligence and careful planning. As of Jan. 4, Providence reported it has given the first dose to more than half of its 120,000 employees in 51 hospitals in seven states. Dr. Compton-Phillips told CNBC planning is a large factor in this success. "All along with COVID-19, we've been think- ing that planning is the antidote to panic," she said, adding that Providence started planning in September for a vaccine and how it would handle distributing it to employees. She said the health system knew tools would be needed to help Providence identify the highest-risk employees, and it considered how it could validate data and then use that data to reach out to people about vaccination using modern tools like texting. "Because we did that planning and we started the rollout as soon as the CDC said they were ready to go, we were ready with our capac- ity to start notifying our caregivers to come get treated with the vaccine," Dr. Compton- Phillips told CNBC. Part of that planning was using artificial intelligence to develop a "validate and verify" tool. Dr. Compton-Phillips said the tool had information about roles and work locations, "everything from doctors to housekeepers to respiratory therapists to IT people." Employees were also asked to verify their risk and role. "I think the biggest lesson is don't hesitate to start doing something. Some immuniza- tions are better than none. And to ask your people, make sure you hear from them, not just trusting the data," Dr. Compton-Phillips told CNBC. n

Articles in this issue

Links on this page

view archives of Becker's ASC Review - January/February 2021 Issue of Becker's ASC Review